Serum and urinary soluble alpha klotho levels in patients with Chronic kidney disease

• Main Authors: Khalid Jamal Al-Jewari, Rayah S. Baban, Jawad Kadhim Manuti
• Format: Article
• Language: English
• Published: College of Medicine, Al-Nahrain University 2021-04-01
• Series: Baghdad Journal of Biochemistry and Applied Biological Sciences
• Subjects: alpha- soluble Klotho; Chronic kidney disease; CKD; eGFR; urinary alpha Klotho
• Online Access: https://bjbabs.org/index.php/bjbabs/article/view/35

Abstract Background: Chronic kidney disease is an epidemic global health problem that leads to death. To prevent any disease progression and treatment, the diagnosis must be made in the early stage by studying renal damage. Klotho is a protein found in many organs of the human body, but it is mainly abundant in the kidney. This study aimed to evaluate klotho's clinical significance as an additional biomarker for diagnosing chronic kidney disease in its early stages.   Methods: One hundred subjects were included in this study to measure their serum and urinary klotho. Forty patients with chronic kidney disease (pre-dialysis)  and sixty normal subjects were enrolled in this study. Serum and urinary klotho were determined using the ELISA technique in addition to other renal function tests. Results : Serum and urinary  alpha klotho  were decreased in CKD patients when it compared with control subjects. A positive correlation was found between serum creatinine and urinary alpha klotho in the patients' group. Conclusion: Serum and Urinary alpha klotho levels were decreased significantly in patients with chronic kidney disease compared with healthy controls.